Mobile App Plus Standard Care Shows Mixed Results for Asthma Control in Malaysian Adults
A 6-month randomized controlled trial at Hospital Pulau Pinang, Malaysia, enrolled 162 adult outpatients with physician-diagnosed asthma. Participants were assigned to receive either the CareAide® mobile application plus standard care or standard care alone, with asthma control measured by the ACQ-7 questionnaire at 6 months.
In the primary analysis of 129 patients who completed follow-up (complete cases), the intervention group had a mean ACQ-7 score of 0.99 compared to 1.34 in the control group. The adjusted mean difference was -0.414 (95% CI -0.783 to -0.045; p = 0.028), indicating a statistically significant improvement in asthma control favoring the mobile app group. However, an intention-to-treat sensitivity analysis using multiple imputation for all 162 randomized patients showed a non-significant adjusted mean difference of -0.350 (95% CI -0.780 to 0.081; p = 0.110).
Safety and tolerability data were not reported. A notable limitation is that 33 patients (20% of the randomized sample) did not complete the 6-month follow-up, potentially affecting the completeness of the primary analysis. Funding sources and conflicts of interest were also not reported.
For practice, this study provides preliminary but mixed evidence regarding the effectiveness of a specific mobile application as an adjunct to standard asthma care. The discrepancy between the complete case and intention-to-treat analyses suggests the findings may be sensitive to missing data. Clinicians should interpret these results cautiously, recognizing that the intervention showed a signal of benefit in one analysis but not in another more conservative analysis.